IL-17 inhibitors are approved for axial spondyloarthritis and psoriatic arthritis, but their effectiveness in heavily ...

Post-operative nausea and vomiting (PONV) market to rise from $2.11B in 2024 to $2.97B in 2029, driven by innovations in ...

New Jersey-based drugmaker Bristol Myers Squibb this month dedicated its first production facility in Indiana, a former north ...

Strictly Come Dancing professional Amy Dowden was diagnosed with breast cancer in 2023 and has opened up about her "daunting" ...

Strictly Come Dancing professional Amy Dowden was diagnosed with breast cancer less than a year after marrying her husband ...

SEDA Experts LLC, a leading expert witness firm providing world-class financial expert witness services, announced today that ...

European regulators on Friday said that the Duchenne muscular dystrophy gene therapy Elevidys should not be approved ...

Bristol Myers Squibb has appointed Dr Cristian Massacesi as Executive Vice President, Chief Medical Officer and Head of ...

Institutional investors including Armistice Capital, RTW Investments, and Wellington Management have increased their exposure ...

In this article, you’ll find some of the top content that was published on LCGC this week, including an ASMS 2025 retrospective and an overview of microplastic research.

New capital, maturing pipelines, and a more global R&D mindset are pushing valuations higher, even as competition tightens.